GENB (Generate Biomedicines) Interest Expense: $ Mil (TTM As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Interest Expense?

Generate Biomedicines GENB +2.18% 6 Interest Expense is $ Mil as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Generate Biomedicines's interest expense for the six months ended in Dec. 2025 was $ -1.14 Mil. Generate Biomedicines does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in Dec. 2025.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Generate Biomedicines's Operating Income for the six months ended in Dec. 2025 was $ -235.07 Mil. Generate Biomedicines's Interest Expense for the six months ended in Dec. 2025 was $ -1.14 Mil. Generate Biomedicines did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Generate Biomedicines  (NAS:GENB) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Generate Biomedicines's Interest Expense for the six months ended in Dec. 2025 was $-1.14 Mil. Its Operating Income for the six months ended in Dec. 2025 was $-235.07 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $53.52 Mil.

Generate Biomedicines's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Generate Biomedicines did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Generate Biomedicines Interest Expense Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Interest Expense Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Interest Expense
-2.12 -1.14

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Interest Expense -2.12 -1.14
GENB
6GF Score
Generate Biomedicines Inc GENB
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $ Mil mean?
Generate Biomedicines (GENB) has a Interest Expense of $ Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Generate Biomedicines and its competitors.
Is Generate Biomedicines' Interest Expense too high?
Generate Biomedicines' current Interest Expense is $ Mil. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' Interest Expense compare to PVLA and SLBT?
Generate Biomedicines' Interest Expense of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Generate Biomedicines and its competitors. Generate Biomedicines's current Interest Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current Interest Expense of $ Mil. The current Interest Expense is $ Mil. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current Interest Expense is $ Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price